Centuple Global Ltd

NSE: RUBRAME · BSE: 531099 · Pharmaceuticals & Biotechnology · 21 announcements

Share price: ₹33.93
Market cap: ₹18.55 Cr
Revenue (annual): ₹573.8 Cr
Net profit (annual): ₹1.51 Cr
P/E (TTM): 15.0×Sector 47.4×
Promoter holding: 0.00%+0.00% QoQ
FII holding: 11.15%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 4 Board Meeting Date 4 Financial Results 3 Debt & Borrowing 2 Board Meeting Outcome 2 Annual General Meeting 2 Price Movement Clarification 1 Other Announcement 1 Legal & Regulatory 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

27 Aug 2026 17:59 IST BSE

Legal & Regulatory

Centuple Global Legal & Regulatory

Centuple Global Limited filed its Annual Secretarial Compliance Report. The report discloses payment of SOP fines amounting to Rs. 0.79 Crore for regulatory non-compliance.

Value: ₹0.79 Cr

Read the filing ↗